Cases
All of our briefs are linked on their respective case pages. If they are helpful to you as an attorney or pro se litigator, please feel welcome to use them.
Johnson v. Peterson
Chronic hepatitis C disproportionately affects incarcerated individuals—by recent estimates, HCV is 17 to 23 times more prevalent among prisoners than the general population. Less than 1% of the United States population is incarcerated today, but roughly 30% of all Americans with HCV reside in prison. According to a 2017 meta-analysis, Ohio’s prison population has one of the highest reported rates of HCV infection as measured by antibody prevalence, at a rate of 36% compared to the national average of 18%.
Melnik v. Aranas
Chronic hepatitis C (HCV) kills more Americans than every other infectious disease combined, and even though effective treatments that eliminate HCV in 99% of cases have been available for a number of years, some prison systems deny treatment to most or all of their patients with HCV due simply to the cost of the drugs.
Van Wagner v. Faulks
Chronic hepatitis C (HCV) kills more Americans than every other infectious disease combined, and even though effective treatments that eliminate HCV in 99% of cases have been available for a number of years, some prison systems deny treatment to most or all of their patients with HCV due simply to the cost of the drugs.
Woodcock v. Correct Care Solutions, LLC
In collaboration with Paul, Weiss, Rifkind, Wharton, and Garrison LLP and the Center for Health Law & Policy Innovation at Harvard Law School, Rights Behind Bars filed an amicus brief on behalf of a group of medical organizations and doctors who specialized in correctional or kidney health.
Mann v. Ohio DRC
In collaboration with Paul, Weiss, Rifkind, Wharton, and Garrison LLP and the Center for Health Law & Policy Innovation at Harvard Law School, Rights Behind Bars filed an amicus brief on behalf of a group of medical organizations and doctors who specialized in correctional or kidney health.